HIV pathogenesis: mechanisms of susceptibility and disease progression.

[1]  F. Plummer,et al.  CCR2-64I allele and genotype association with delayed AIDS progression in African women , 1998, The Lancet.

[2]  J. Phair,et al.  A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation , 1998, Nature Medicine.

[3]  J J Goedert,et al.  Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) , 1998, Science.

[4]  Luc Montagnier,et al.  HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene , 1998, The Lancet.

[5]  E. Rosenberg,et al.  Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. , 1997, Science.

[6]  M. Clerici,et al.  HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals , 1997, Nature Medicine.

[7]  J J Goedert,et al.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.

[8]  J. Bronowicki,et al.  Lymphocyte reactivity to hepatitis C virus (HCV) antigens shows evidence for exposure to HCV in HCV-seronegative spouses of HCV-infected patients. , 1997, The Journal of infectious diseases.

[9]  L. Montagnier,et al.  Influence of microbial infections on the progression of HIV disease. , 1997, Trends in microbiology.

[10]  J. Whitworth,et al.  HIV-1 disease progression and AIDS-defining disorders in rural Uganda , 1997, The Lancet.

[11]  T. Greenough,et al.  Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. , 1997, The Journal of infectious diseases.

[12]  M. Newport.  Unravelling the genetic basis of susceptibility to infectious diseases , 1997 .

[13]  J. Giorgi,et al.  Concomitant killing in vitro of both gp120-coated CD4+ peripheral T lymphocytes and natural killer cells in the antibody-dependent cellular cytotoxicity (ADCC) system. , 1997, Journal of Immunology.

[14]  R. Royce,et al.  Sexual transmission of HIV. , 1997, The New England journal of medicine.

[15]  K. Rosenthal,et al.  CD8+ T cell‐mediated suppression of HIV long terminal repeat‐driven gene expression is not associated with improved clinical status , 1997, AIDS.

[16]  Martin A. Nowak,et al.  Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.

[17]  M. McElrath,et al.  HIV-1 Induces Cytotoxic T Lymphocytes in the Cervix of Infected Women , 1997, The Journal of experimental medicine.

[18]  Yan Cui,et al.  Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  N. Nagelkerke,et al.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya , 1996, The Lancet.

[20]  M. Daly,et al.  Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Levy,et al.  Role of IL-16 in HIV replication , 1996, Nature.

[22]  L. Papagno,et al.  Chemokine production in HIV-seropositive long-term asymptomatic individuals. , 1996, AIDS.

[23]  Y. Chen,et al.  CD8+ T-cell-mediated suppression of HIV-1 infection may not be due to chemokines RANTES, MIP-1 alpha and MIP-1 beta. , 1996, AIDS.

[24]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[25]  R. Means,et al.  Serum chemokine levels in patients with non-progressing HIV infection , 1996, AIDS.

[26]  R. Brunham,et al.  Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. , 1996, Journal of immunology.

[27]  S. Africa.,et al.  Sexually transmitted diseases in South Africa. , 1996, Genitourinary medicine.

[28]  J. Levy,et al.  Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells. , 1996, Immunology today.

[29]  Steven M. Wolinsky,et al.  Relative resistance to HIV–1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high–risk sexual exposures , 1996, Nature Medicine.

[30]  J. Goedert,et al.  Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection , 1996, Nature Medicine.

[31]  S. Bartz,et al.  γδ T lymphocyte responses to HIV , 1996 .

[32]  Anthony S. Fauci,et al.  Toward an Understanding of the Correlates of Protective Immunity to HIV Infection , 1996, Science.

[33]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[34]  K. Nelson,et al.  Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand , 1995, AIDS.

[35]  J. Todd,et al.  Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial , 1995, The Lancet.

[36]  J. Berzofsky,et al.  ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. , 1995, The Journal of clinical investigation.

[37]  A. Dessein,et al.  Schistosoma‐specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2 , 1995, European journal of immunology.

[38]  N. Meda,et al.  Sexually Transmitted Diseases and Human Immunodeficiency Virus Infection among Women with Genital Infections in Burkina Faso , 1995, International journal of STD & AIDS.

[39]  I. Thior,et al.  Natural protection against HIV-1 infection provided by HIV-2. , 1995, Science.

[40]  S. Rowland-Jones,et al.  HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.

[41]  N. Nagelkerke,et al.  Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. , 1995, The Journal of infectious diseases.

[42]  D. Ho,et al.  Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. , 1995, The New England journal of medicine.

[43]  M. Clerici,et al.  T‐cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques , 1994, AIDS.

[44]  P. Piot,et al.  Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers , 1994, The Lancet.

[45]  F. Wignall,et al.  Natural history of HIV infection in Filipino female commercial sex workers. , 1994, Journal of acquired immune deficiency syndromes.

[46]  É. Oksenhendler,et al.  Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. , 1994, The Journal of clinical investigation.

[47]  J. Levy,et al.  HIV pathogenesis and long-term survival. , 1993, AIDS.

[48]  M. Clerici,et al.  A strategy for prophylactic vaccination against HIV. , 1993, Science.

[49]  S. Rowland-Jones,et al.  HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant , 1993, The Lancet.

[50]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[51]  H. Bielefeldt-Ohmann,et al.  Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. , 1992, Science.

[52]  J. Berzofsky,et al.  Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. , 1992, The Journal of infectious diseases.

[53]  J. Wasserheit,et al.  Epidemiological Synergy: Interrelationships between Human Immunodeficiency Virus Infection and Other Sexually Transmitted Diseases , 1992, Sexually transmitted diseases.

[54]  A. Phillips,et al.  Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment. , 1991, BMJ.

[55]  L. Abel,et al.  Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. , 1991, American journal of human genetics.

[56]  T. Mosmann,et al.  The role of IL-10 in crossregulation of TH1 and TH2 responses. , 1991, Immunology today.

[57]  G. Rutherford,et al.  Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. , 1990, BMJ.

[58]  N. Nagelkerke,et al.  Transition dynamics of HIV disease in a cohort of African prostitutes: a Markov model approach. , 1990, AIDS.

[59]  P Piot,et al.  HIV infection among lower socioeconomic strata prostitutes in Nairobi. , 1990, AIDS.

[60]  R. Brunham,et al.  FEMALE TO MALE TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1: RISK FACTORS FOR SEROCONVERSION IN MEN , 1989, The Lancet.

[61]  F. Plummer,et al.  PREVENTION OF TRANSMISSION OF HUMAN IMMUNODEFICIENCY VIRUS IN AFRICA: EFFECTIVENESS OF CONDOM PROMOTION AND HEALTH EDUCATION AMONG PROSTITUTES , 1988, The Lancet.

[62]  P. Piot,et al.  Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa. , 1988, The New England journal of medicine.

[63]  R. Fernandez-Botran,et al.  Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells , 1988, The Journal of experimental medicine.

[64]  J. Convit,et al.  Learning from lesions: patterns of tissue inflammation in leprosy. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[65]  T. Mosmann,et al.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies , 1987, The Journal of experimental medicine.

[66]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[67]  Forbes Cd,et al.  Letter: Haemophilia carriers. , 1974 .

[68]  B. Culliton.  The microbial plague continues , 1997, Nature Medicine.

[69]  C. Broder,et al.  HIV and the 7-transmembrane domain receptors. , 1996, Pathobiology : journal of immunopathology, molecular and cellular biology.

[70]  F. Plummer,et al.  Sexual transmission of HIV and the role of sexually transmitted diseases , 1994 .

[71]  P. Piot,et al.  Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. , 1993 .

[72]  R. Brunham,et al.  The interaction of HIV infection and other sexually transmitted diseases: an opportunity for intervention. , 1989, AIDS.